Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

Neurogene NASDAQ: NGNE stock just took a sharp dive, plummeting 44% in a single day. Neurogene TodayNGNENeurogene$39.66 -0.34 (-0.85%) 52-Week Range$12.49▼$74.49Price Target$63.33Add to WatchlistBad news on Monday caused the pharmaceutical company’s shares to drop massively in after-hours trading, and they continued to slide through Tuesday. So, what was it that sent shares of Neurogene, a stock that was up 269% year-to-date, plummeting? And more importantly, is all hope lost for this clinical-stage biotec ...